Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News General Mills launches high-protein cereal Wheaties Protein to fuel modern athletes This spring, Wheaties, the iconic cereal brand known for celebrating athletic achievements, is expanding its product line with… byPallavi MadhirajuApril 22, 2024